New device aims to prevent leaks after colon cancer surgery

NCT ID NCT06402188

Recruiting now Disease control Sponsor: Averto Medical, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a device called ColoSeal ICD that is placed inside the colon after surgery to divert stool away from the surgical connection. The goal is to see if it is safe and feasible in 90 adults with rectal or rectosigmoid cancer. The device stays in place for about 10 days and is then removed.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ColoSeal ICD Device (a temporary tube placed in the colon to divert stool away from a surgical connection)
What this could lead to: If it works, this device could reduce the risk of serious leaks after colon surgery, potentially making recovery safer and faster.
What could go wrong: This is an early feasibility study with only 90 participants, so results may not apply to everyone. The device could cause infection, migration, or other complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal cancer colorectal neoplasm rectal cancer rectosigmoid carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COLORECTAL CANCER

Contacts and locations

Locations

Israeli-Georgian Medical Research Clinic Healthycore
COMPLETED

Tbilisi, 0112, Georgia
National Cancer Institute
RECRUITING

Tashkent, Uzbekistan
National Center of Oncology after V.A. Fanarjian
RECRUITING

Yerevan, Armenia

More trials for these conditions

Other studies related to the condition(s) this trial covers.